Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The Goodwill Estate, offered for $17.5 million, has a long history, established in 1795, it is listed on the National Register of Historic Places.
-
CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market...
-
RALEIGH, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE: HIW) has published its 2023 Corporate Resiliency Report, which highlights the Company’s Environmental, Social and...
-
ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...
-
Chiffre d’affaires en hausse de +3,8 % au 1er trimestre 2024, à 265,0 M€ Poursuite de la forte croissance au Benelux Confirmation du puissant relais de croissance offert par les activités liées à la...
-
Revenue up +3.8% in Q1 2024 to €265.0 million Continued strong growth in the Benelux Energy transition-related activities confirmed as a powerful growth driverContinued rebalancing of the business mix...
-
RESTON, Virginia, May 13, 2024 (GLOBE NEWSWIRE) -- May 13, 2024 – Stanley Martin Holdings announced today that it has entered into an agreement to acquire Prestige Corporate Development (a land...
-
CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to...
-
Q3 Revenue Up 7% Quarter-Over-Quarter Filter-Related Revenue Up 13% Quarter-Over-Quarter, Third Highest in Company History Growth, Cost Savings Initiatives, CHIPS Act ITC Refund Support...
-
– NDA for etripamil in PSVT resubmitted in 1Q 2024– Cash resources as of March 31, 2024 expected to fund operations into 2026– Dialogue with FDA to finalize Phase 3 protocol for etripamil in AFib-RVR...